These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy. Abrams WB; Davies RO; Ferguson RK Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular drugs in children. II. Angiotensin-converting enzyme inhibitors in pediatric patients. Schneeweiss A Pediatr Cardiol; 1990 Oct; 11(4):199-207. PubMed ID: 2274447 [No Abstract] [Full Text] [Related]
6. Effectiveness of low dose captopril versus propranolol therapy in infants with severe congestive failure due to left-to-right shunts. Buchhorn R; Ross RD; Hulpke-Wette M; Bartmus D; Wessel A; Schulz R; Bürsch J Int J Cardiol; 2000; 76(2-3):227-33. PubMed ID: 11104878 [TBL] [Abstract][Full Text] [Related]
7. [What have we learned about inhibitors of the renin-angiotensin system?]. Waeber B; Nussberger J; Brunner HR Ann Endocrinol (Paris); 1986; 47(3):167-77. PubMed ID: 3022638 [TBL] [Abstract][Full Text] [Related]
8. Comparisons of long-term effects between converting enzyme inhibitors and conventional therapy in treating mild to moderate hypertension. Lin M; Chiang HT; Chen CY Zhonghua Yi Xue Za Zhi (Taipei); 1991 Nov; 48(5):339-50. PubMed ID: 1659934 [TBL] [Abstract][Full Text] [Related]
10. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success]. Borghi C; Cosentino E; De Sanctis D Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921 [TBL] [Abstract][Full Text] [Related]
11. Drug suppression of the angiotensin system in congestive heart failure. Sullivan JM Annu Rev Med; 1983; 34():169-77. PubMed ID: 6190432 [TBL] [Abstract][Full Text] [Related]
12. Blockade of the renin-angiotensin system. Cheung BM Hong Kong Med J; 2002 Jun; 8(3):185-91. PubMed ID: 12055364 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme inhibitors in perspective: an update. Burrell LM; Johnston CI Aust Fam Physician; 1993 Jul; 22(7):1243-7, 1251, 1255. PubMed ID: 8373316 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors in hypertension: a review. Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
17. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753 [TBL] [Abstract][Full Text] [Related]
18. Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure. Cody RJ; Laragh JH; Atlas SA; Case DB J Hypertens Suppl; 1983 Oct; 1(1):77-84. PubMed ID: 6085835 [TBL] [Abstract][Full Text] [Related]
19. Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease. Vonder Muhll I; Liu P; Webb G Int J Cardiol; 2004 Dec; 97 Suppl 1():25-33. PubMed ID: 15590076 [TBL] [Abstract][Full Text] [Related]